TORONTO, Feb. 28, 2012 /CNW Telbec/ - Mark Lievonen, President of Sanofi
Pasteur Limited, wishes to congratulate players of the Langley British
Columbia Little League baseball team and their families and supporters
for the initiative and success of the Canada-Uganda Pearl of Africa
"This was more than just a baseball game," says Mr. Lievonen. "This was
a small group of Canadians who made a difference in a very big way."
Seven months ago, it was announced that the first African team ever to
qualify for the Little League World Series would not have the chance to
compete. Many players' visa applications for travel to the United
States were denied because their birth certificates were unavailable, a
common situation in a country where many people are not born in
hospitals. Uganda was scheduled to play Canada in August in
When British Columbia resident Ruth Hoffman read about the Ugandan
team's disappointment, she felt it was a great injustice. "These young
players had worked and trained very hard to earn their spot in the
World Series, and I was shocked to see that they were denied this
once-in-a-lifetime opportunity," she says. She put her disappointment
into action and quickly teamed up with Right To Play, a non-profit
organization dedicated to improving the lives of children in some of
the world's poorest areas through the power of sport and play.
With support from Right To Play and many donors and sponsors, they
helped the Canadian team raise the funds needed to cover the cost of
sending them to Africa so they could play the game they were meant to
play. In fact, they did so well that they also raised enough money to
contribute to other initiatives that will benefit the Ugandan players
for years to come.
"We're really proud that Sanofi Pasteur played a role in this
extraordinary mission," explains Mr. Lievonen. The company donated the
various vaccines needed by the team to travel overseas, protecting the
young players from meningococcal disease, hepatitis A and yellow fever.
"We're also very thankful to our partner, the International Travel
Health and Vaccination Clinic in Langley BC, which administered the
"The Ugandan team ended up winning the historic game in Nakirebe 2 to 1,
but it's fair to say that everyone involved came away with a new sense
of pride and accomplishment--and this is what team spirit is all
about!" concludes Mr. Lievonen.
Sanofi, a global and diversified healthcare leader, discovers, develops
and distributes therapeutic solutions focused on patients' needs.
Sanofi has core strengths in the field of healthcare with seven growth
platforms: diabetes solutions, human vaccines, innovative drugs, rare
diseases, consumer healthcare, emerging markets and animal health.
Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1
billion doses of vaccine each year, making it possible to immunize more
than 500 million people across the globe. A world leader in the vaccine
industry, Sanofi Pasteur offers the broadest range of vaccines
protecting against 20 infectious diseases. The company's heritage, to
create vaccines that protect life, dates back more than a century.
Sanofi Pasteur is the largest company entirely dedicated to vaccines.
Every day, the company invests more than EUR 1 million in research and
development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us
Forward Looking Statements
This press release contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995, as amended.
Forward-looking statements are statements that are not historical
facts. These statements include projections and estimates and their
underlying assumptions, statements regarding plans, objectives,
intentions and expectations with respect to future financial results,
events, operations, services, product development and potential, and
statements regarding future performance. Forward-looking statements are
generally identified by the words "expects", "anticipates", "believes",
"intends", "estimates", "plans" and similar expressions. Although
Sanofi's management believes that the expectations reflected in such
forward-looking statements are reasonable, investors are cautioned that
forward-looking information and statements are subject to various risks
and uncertainties, many of which are difficult to predict and generally
beyond the control of Sanofi, that could cause actual results and
developments to differ materially from those expressed in, or implied
or projected by, the forward-looking information and statements. These
risks and uncertainties include among other things, the uncertainties
inherent in research and development, future clinical data and
analysis, including post marketing, decisions by regulatory
authorities, such as the FDA or the EMA, regarding whether and when to
approve any drug, device or biological application that may be filed
for any such product candidates as well as their decisions regarding
labeling and other matters that could affect the availability or
commercial potential of such products candidates, the absence of
guarantee that the products candidates if approved will be commercially
successful, the future approval and commercial success of therapeutic
alternatives, the Group's ability to benefit from external growth
opportunities as well as those discussed or identified in the public
filings with the SEC and the AMF made by Sanofi, including those listed
under "Risk Factors" and "Cautionary Statement Regarding
Forward-Looking Statements" in Sanofi's annual report on Form 20-F for
the year ended December 31, 2010. Other than as required by applicable
law, Sanofi does not undertake any obligation to update or revise any
forward-looking information or statements.
Image with caption: "The Canadian Little League Team in Uganda (CNW Group/SANOFI PASTEUR)". Image available at: http://photos.newswire.ca/images/download/20120228_C8064_PHOTO_EN_10511.jpg
SOURCE SANOFI PASTEUR
For further information: